In the context of COPD, cigarette smoke as a major etiology triggers the activation of NF-κB and MAPK signaling pathways, leading to the release of pro-inflammatory cytokines and chemokines, thereby perpetuating the inflammatory cycle and tissue damage [48]. Here, NFKB1 is linked to chronic obstructive pulmonary disease.